Nucleix Competitors and Similar CompaniesClear all

Nucleix's competitors and similar companies include nRichDX, Inanovate, Mursla and Chundsell Medicals.
Nucleix
Nucleix
Nucleix is a company that develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.
nRichDX
nRichDX
nRichDX is a biotech company providing liquid biopsy sample preparation for molecular testing.
Inanovate
Inanovate
Inanovate is a company developing technology for screening and analyzing proteins.
Mursla
Mursla
Mursla is a cancer liquid biopsy company.
Chundsell Medicals
Chundsell Medicals
Chundsell Medicals is a company working with prostate cancer patients
Founding Date
Founding Date
2008
Founding Date
N/A
Founding Date
2007
Founding Date
2017
Founding Date
2007
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Rehovot, IL HQ
San Diego, US
Locations
Irvine, US HQ
Locations
Sioux Falls, US HQ
Raleigh, US
Locations
Cambridge, GB HQ
Milton, GB
Locations
Solna, SE HQ
Solna, SE
Employees
Employees
72
Employees
18
Employees
19
Employees
16
Employees
109% decrease

Funding

Latest funding round
Latest funding round
$ 55m (about 5 years ago)
Latest funding round
N/A
Latest funding round
$ 3.1m (about 7 years ago)
Latest funding round
$ 2m (almost 9 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 61m
Total funding raised
N/A
Total funding raised
$ 3.6m
Total funding raised
$ 2m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

nRichDX
HQ
Irvine, US
Employees
18

nRichDX is a biotech company providing liquid biopsy sample preparation for molecular testing.

View company
Inanovate
HQ
Sioux Falls, US
Employees
19

Inanovate is a company developing technology for screening and analyzing proteins.

View company
Mursla
HQ
Cambridge, GB
Employees
16

Mursla is a cancer liquid biopsy company.

View company
Chundsell Medicals
HQ
Solna, SE
Employees
10↓ 9% decrease

Chundsell Medicals is a company working with prostate cancer patients

View company